One of the rare but early prognostically important mutations in clinically aggressive meningiomas was the TERTp mutation, found to be present in 16/252 (6.4%) of meningiomas in one study and were associated with significantly shorter TTP compared to TERT wild-type meningiomas irrespective of WHO grade. This evidence concerns the gene TERT and meningioma.